Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Drugpatentwatch trametinib?
Mobic injection patent oehringer ingelheim france?
Patent tenofovir alafenamide gilead?
Brenzavvy discontinuation?
Zemdri nce gain exclusivity 2028 patent 2031?

Abrocitinib iupac name?

See the DrugPatentWatch profile for Abrocitinib

Abrocitinib's IUPAC name is 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-1-yl)-1-methyl-3-(3-methyl-1H-pyrazol-5-yl)-1-oxopropan-2-yl acetate [1].



Other Questions About Abrocitinib :

wo2020008391 abrocitinib manufacturing process patent google patents Abrocitinib large scale synthesis patent process pharmaceutical composition? Abrocitinib synthesis patent process large scale pharmaceutical composition? Abrocitinib large scale synthesis process patent? Us10815240b2 abrocitinib patent pdf? Pfizer abrocitinib manufacturing process patent? Abrocitinib cost?

AI-Drug Label Prescribing Information Alignment Report

Try it Free

Drug Brand Mention Assessment

Branding Score
31
Visibility
25
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Core Claims
  • Abrocitinib's IUPAC name is 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-1-yl)-1-methyl-3-(3-methyl-1H-pyrazol-5-yl)-1-oxopropan-2-yl acetate
Differentiators
Pricing Perception: Not Mentioned